VYCO - Vycor Medical, Inc.
| Previous Close | 0.18375 |
| Open | 0.00000 |
| Bid | 0.00000 x 0 |
| Ask | 0.00000 x 0 |
| Day's Range | 0.00000 - 0.00000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 4,000 |
| Market Cap | 4.082M |
| Beta (3Y Monthly) | -0.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09200 |
| Earnings Date | Mar 29, 2018 - Apr 2, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE•8 months ago
Vycor Medical Reports Financial Results for the Year Ended December 31st, 2017
BOCA RATON, FL / ACCESSWIRE / March 30, 2018 / Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ...
- PR Newswire•8 months ago
Vycor Announces That it is Accelerating the Roll-out of its Enhanced VBAS due to Surgeon Feedback
Vycor Medical, Inc. (VYCO) had previously announced in October 2017 to its customer base the release of its enhanced VBAS, which it would be slowly rolling out over the course of this year as it ran down its inventory of the current VBAS. Following surgeon feedback Vycor has decided that it will from now be shipping only the enhanced model VBAS across the complete main range of 12 VBAS sizes. As previously announced the Company has been working on improving how its VBAS integrates with the most common Image Guidance System ("IGS") pointers on the market.
- Capital Cube•last year
Vycor Medical, Inc. :VYCO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
Categories: Yahoo FinanceGet free summary analysis Vycor Medical, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Vycor Medical, Inc. – Alphatec Holdings, Inc., NuVasive, Inc., Xtant Medical Holdings, Inc., CAS Medical Systems, Inc. and TransEnterix, Inc. (ATEC-US, NUVA-US, XTNT-US, CASM-US and TRXC-US) that have ... Read more (Read more...)
